Moderna in talks with Japan to supply 40 million doses of Covid-19 vaccine
The vaccine candidate, mRNA-1273, would be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical Co Ltd, beginning in the first half of 2021, if it receives regulatory approval
A sign marks the headquarters of Moderna Inc, which is developing a vaccine against the coronavirus, in Cambridge, Massachusetts, US, May 18, 2020. Reuters/Brian Snyder/File Photo
Moderna Inc said on Friday it was in talks with Japan's government to potentially supply 40 million or more doses of its Covid-19 vaccine candidate.
The vaccine candidate, mRNA-1273, would be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical Co Ltd, beginning in the first half of 2021, if it receives regulatory approval.
